시장보고서
상품코드
1741511

진료 단위형 의료 서비스 시장 : 제품 유형별, 용도별, 유통 채널별, 지역별

Per-Encounter Medical Market, By Product Type, By Application, By Distribution Channel, By Geography

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

진료 단위형 의료 서비스 시장은 2025년에는 1,562억 5,000만 달러, 2032년에는 4,416억 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 16%로 성장할 전망입니다.

보고 범위 보고서 세부정보
기준 연도 2024년 2025년 시장 규모 1,562억 5,000만 달러
실적 데이터 2020-2024년 예측 기간 2025-2032년
예측 기간 : 2025-2032년 CAGR : 16.00% 2032년 가치 예측 4,416억 달러

진료 단위형 의료 서비스는 기존의 피포 서비스 모델이 아닌 방문당 제공되는 의료 서비스입니다.

세계의 진료 단위형 의료 서비스 시장은 다양한 요인에 의해 큰 성장을 이루고 있습니다.

시장 역학 :

세계의 진료 단위형 의료 서비스 시장은 몇 가지 촉진요인에 의해 지원되고 있습니다. 의료비 상승으로 인해 환자들은 경제적으로 실행 가능한 대체 치료 옵션을 찾고 있습니다. 또한 만성 질환 증가나 고령화도, 창구 의료 서비스 수요를 높이고 있습니다. Cancer Facts &Figures' 보고서에 따르면 미국에서는 약 190만명이 새롭게 암으로 진단되었으며 60만9,360명이 사망한 것으로 보고되었습니다.

그러나 시장에 억제요인도 있습니다. 보험 상환 정책의 부족과 표준화된 규제와 정책의 부재는 진료 단위형 의료 서비스 시장의 성장을 방해할 가능성이 있습니다.

이러한 과제에도 불구하고 진료 단위형 의료 서비스 시장에는 충분한 비즈니스 기회가 있습니다. 이러한 기술을 통해 의료 제공자는 소외된 지역에 도달하여 가상으로 의료 서비스를 제공함으로써 진료 단위형 의료 서비스의 성장을 촉진할 수 있습니다.

본 조사의 주요 특징

  • 본 보고서에서는 세계의 진료 단위형 의료 서비스 시장을 상세하게 분석했으며, 2024년을 기준연도로서, 2025년부터 2032년까지의 예측 기간에 있어서 시장 규모 및 CAGR을 제공합니다.
  • 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
  • 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
  • 본 보고서에서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해 세계의 진료 단위형 의료 서비스장에 있어서의 주요 기업 프로파일을 제공합니다.
  • 본 보고서로부터의 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
  • 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 하고 있습니다.
  • 이해관계자는 세계의 진료 단위형 의료 서비스 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 만성질환의 유병률 상승
    • 엄격한 규제 요건
    • 신흥 시장 확대
  • 주요 하이라이트
  • 규제 시나리오
  • 최근 동향
  • 제품 출시/승인
  • PEST 분석
  • PORTER 분석
  • 합병, 인수 및 제휴

제4장 세계의 진료 단위형 의료 서비스 시장, 코로나 바이러스(COVID-19) 유행의 영향

  • COVID-19 역학
  • 공급측과 수요측의 분석
  • 경제에 미치는 영향

제5장 세계의 진료 단위형 의료 서비스 시장, 제품 유형별, 2020년-2032년

  • 소모품
  • 디바이스
  • 소프트웨어
  • 서비스
  • 기타

제6장 세계의 진료 단위형 의료 서비스 시장, 용도별, 2020년-2032년

  • 심장병학
  • 정형외과
  • 산부인과
  • 안과
  • 소화기내과
  • 기타

제7장 세계의 진료 단위형 의료 서비스 시장, 유통 채널별, 2020년-2032년

  • 직접 판매
  • 소매 매출
  • 온라인 판매

제8장 세계의 진료 단위형 의료 서비스 시장, 지역별, 2020년-2032년

  • 북미
      • 미국
      • 캐나다
  • 유럽
      • 독일
      • 영국
      • 스페인
      • 프랑스
      • 이탈리아
      • 러시아
      • 기타 유럽
  • 아시아태평양
      • 중국
      • 인도
      • 일본
      • 호주
      • 한국
      • ASEAN
      • 기타 아시아태평양
  • 라틴아메리카
      • 아르헨티나
      • 브라질
      • 멕시코
      • 기타 라틴아메리카
  • 중동
      • GCC 국가
      • 이스라엘
      • 기타 중동
  • 아프리카
      • 남아프리카
      • 중앙 아프리카
      • 북아프리카

제9장 경쟁 구도

  • 기업 프로파일
    • Catalent Inc.
    • Smiths Medical Inc.
    • Cardinal Health
    • Schott
    • Nipro Corporation
    • Terumo Corporation
    • Gerresheimer AG
    • Becton, Dickinson and Company
    • Braun Melsungen AG
    • AngioDynamics Inc.
    • Teleflex Incorporated
    • Argon Medical Devices, Inc.
    • ICU Medical, Inc.
    • Medical Components, Inc.
    • Vygon(UK) Ltd

제10장 섹션

  • 참고문헌
  • 조사 방법
  • 출판사에 대해
SHW 25.06.17

Per-Encounter Medical Market is estimated to be valued at USD 156.25 Bn in 2025 and is expected to reach USD 441.6 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 156.25 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 16.00% 2032 Value Projection: USD 441.6 Bn

Per-encounter medical services refer to medical treatments provided on a per-visit basis, rather than the traditional fee-for-service model. This approach is revolutionizing the healthcare landscape by offering more cost-effective and convenient care options for patients.

Global per-encounter medical market is experiencing considerable growth due to various factors. Patients are increasingly seeking more affordable healthcare options, and per-encounter medical services provide an attractive alternative. Advancements in technology have made it possible to deliver high-quality care remotely, further driving the demand for per-encounter medical services.

Market Dynamics:

Global per-encounter medical market is propelled by several drivers. Firstly, the rising healthcare costs are prompting patients to seek alternative care options that are economically viable. Per-encounter medical services offer transparent pricing and allow patients to pay only for the services they need, thus making healthcare more accessible. Moreover, the increasing prevalence of chronic diseases and the aging population further contribute to the demand for per-encounter medical services. Increasing prevalence of diseases such as cancer and end stage renal disease, which require longer duration therapies (dialysis and chemotherapy) is expected to drive the market growth. For instance, in January 2022according to data published in the Cancer Facts & Figures report by the American Cancer Society, , around 1.9 million new cancer cases was estimated to be diagnosed and 609,360 cancer deaths were reported in the U.S.

However, the market also has restraints. Lack of reimbursement policies and the absence of standardized regulations can hinder the growth of the per-encounter medical market. There may be concerns regarding the quality and continuity of care, as per-encounter medical services focus more on episodic care rather than comprehensive medical management.

Despite these challenges, the per-encounter medical market presents ample opportunities. The growing adoption of telemedicine and remote monitoring technologies provide a potential avenue for expansion. These technologies enable healthcare providers to reach underserved areas and offer healthcare services virtually, thereby fostering the growth of per-encounter medical services. Furthermore, collaborations between healthcare providers and insurance companies can help address reimbursement concerns and drive market growth.

Key features of the study:

  • This report provides in-depth analysis of the global per-encounter medical market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global per-encounter medical market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., and Vygon (UK) Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global per-encounter medical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global per-encounter medical market

Detailed Segmentation:

  • Global Per-Encounter Medical Market, By Product Type
    • Consumables
    • Devices
    • Software
    • Services
    • Others
  • Global Per-Encounter Medical Market, By Application
    • Cardiology
    • Orthopedics
    • Obstetrics/Gynecology
    • Ophthalmology
    • Gastroenterology
    • Others
  • Global Per-Encounter Medical Market, By Distribution Channel
    • Direct Tender
    • Retail Sales
    • Online Sales
  • Global Per-Encounter Medical Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Catalent Inc.
    • Smiths Medical Inc.
    • Cardinal Health
    • Schott
    • Nipro Corporation
    • Terumo Corporation
    • Gerresheimer AG
    • Becton, Dickinson and Company
    • B.Braun Melsungen AG
    • AngioDynamics Inc.
    • Teleflex Incorporated
    • Argon Medical Devices, Inc.
    • ICU Medical, Inc.
    • Medical Components, Inc.
    • Vygon (UK) Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising prevalence of chronic diseases
    • Stringent regulatory requirements
    • Emerging markets expansion
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Per-Encounter Medical Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Per-Encounter Medical Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Per-Encounter Medical Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Obstetrics/Gynecology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Gastroenterology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Per-Encounter Medical Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Direct Tender
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Retail Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Online Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Per-Encounter Medical Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Argentina
      • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • South Africa
      • Central Africa
      • North Africa

9. Competitive Landscape

  • Company Profile
    • Catalent Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Smiths Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Schott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nipro Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Gerresheimer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • AngioDynamics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Argon Medical Devices, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • ICU Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Medical Components, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Vygon (UK) Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제